Answers are grounded in this paper and cite their sources.
In this continuous clinical evaluation, BRCA2 is the most frequently identified prostate cancer gene with over 10% involvement in metastatic disease. BRCA2 and CDK12 somatic PVs do not appear to be mutually exclusive. BRCA1 does not appear to be a significant contributor to prostate cancer progression.
No takes yet. Share an insight, caveat, or question.
Evans et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: